- Young, R.C. (2002) "Cancer statistics, 2002: progress or cause for concern?", CA Cancer J. Clin. 52, 6-7.
- Zwiebel, J.A. and Cheson, B.D. (1998) "Chronic lymphocytic leukemia: staging and prognostic factors", Semin. Oncol. 25, 42-59.
- Binet, J.L., Auquier, A., Dighiero, G., et al. (1981) "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis", Cancer 48, 198-206.
- Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. and Pasternack, B.S. (1975) "Clinical staging of chronic lymphocytic leukemia", Blood 46, 219-234.
- Keating, M.J. (1999) "Chronic lymphocytic leukemia", Semin. Oncol. 26, 107-114.
- Momserrat, E., Sanchez-Bisono, J., Vinolas, N. and Rozman, C. (1986) "Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance", Br: J. Haematol. 62, 567-575.
- Rozman, C., Monsterrat, E., Rodriguez-Fernandez, J.M., et al. (1984) "Bone marrow histologic pattern--the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases", Blood 64, 642-648.
- Dohner, H., Stilgenbauer, S., Benner, A., et al. (2000) "Genomic aberrations and survival in chronic lymphocytic leukemia", N. Engl. J. Med. 343, 1910-1916.
- Damle, R.N., Wasil, T., Fais, F. et al. (1999) "Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia", Blood 94, 1840-1847
- Del Poeta, G., Maurillo, L., Venditti, A., et al. (2001) "Clinical significance of CD38 expression in chronic lymphocytic leukemia", Blood 98, 2633-2639.
- Ibrahim, S., Keating, M., Do, K.A., et al. (2001) "CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia", Blood 98, 181-186.
- D'Arena, G., Muslo, P., Cascavilla, N., et al. (2001) "CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia", Leuk. Lymphoma 42, 109-114.
- Durig, J., Naschar, M., Schmucker, U., et al. (2002) "CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia", Leukemia 16, 30-35.
- Hamblin, T.J., Orchard, J.A. Ibbotson, R.E., et al. (2002) "CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease", Blood 99, 1023-1029.
- Jelinek, D.F., Tschumper, R.C., Geyer, S.M., et al. (2001) "Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia", Br. J. Haematol. 115, 854-861.
- Liu, Y.C., Cleveland, R.P., Madelaire, C. and Hines, J.D. (1995) "Discordant immunophenotype of chronic B-cell lymphoproliferative disorders in simultaneous specimens from bone marrow and peripheral sites", Arch. Pathol. lab. Med. 119, 53-58.
- Pinto, A., Del Vecchio, L., Carbone, A., et al. (1991) "Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia", Ann. Oncol. 2(Suppl. 2), 107-113
- Pinto, A., Zagonel, V., Carbone, A. and Del Vecchio, L. (1992) "Expression of myeloid associated antigens in chronic lymphocytic leukaemia", Br. J. Haematol. 82, 173-175.
- Tassies, D., Montserrat, E., Reverter, J.C., Villamor, N., Rovira, M. and Rozman, C. (1995) "Myelomonocytic antigens in B-cell chronic lymphocytic leukemia", Leuk. Res. 19, 841-848.
- Molica, S. (1992) "Myelomonocytic associated antigens in early B-chronic lymphocytic leukemia correlate with disease activity", Am. J. Hematol. 40, 319-320
- Pinto, A. and Del Vecchio, L. (1988) "Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells", Blood 72, 1438.
- Callea, V., Murabito, F., Oliva, B.M., et al. (1999) "Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcome", Br. J. Haematol. 107, 347-352.
- Chang, C. and Cleveland, R.P. (2002) "Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course", Blood 100,1106.
Relative Importance of CD38 Expression Over Myeloid-associated Markers Expression in Predicting the Clinical Course of B-CLL Patients
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.